29 April 2023

Two The Nicholas Hall CHC Marketing Awards 2023 for Polpharma products!

On April 21, during the Nicholas Hall CHC Marketing Awards 2023 gala in London, Polpharma was awarded for two products - Dorminox and Maxigra. Dorminox received the first prize in the category The European New Product of the Year (the first replacement of doxylamine from prescription to over-the-counter in Poland), and the third place in the Colin Borg Creative Award went to Maxigra (the first global introduction of tadalafil as a medicine without a prescription).
The Nicholas Hall CHC Marketing Awards 2023 recognizes the best marketing efforts and outstanding achievements in the pharmaceutical market. This is one of the most significant awards in the industry.

Polpharma on its websites and mobile applications (“Website”) uses cookies and other related technologies (“cookies”). Self-management of cookies is possible by changing the settings in your web browser. If you do not agree to the collection of personal data through cookies, you can change the settings in your web browser or leave the Website.

By using the Website without changing the settings in your web browser, you accept Polpharma’s use of cookies. By accepting the settings in your web browser, you agree to profiling based on the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect the lawfulness of the processing that was carried out on the basis of consent before its withdrawal.

More information can be found in the Cookies Policy.